232 related articles for article (PubMed ID: 31708104)
21. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
24. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
25. Flavopereirine induces cell cycle arrest and apoptosis via the AKT/p38 MAPK/ERK1/2 signaling pathway in human breast cancer cells.
Yeh HT; Tsai YS; Chen MS; Li YZ; Lin WC; Lee YR; Tseng YS; Sheu SM
Eur J Pharmacol; 2019 Nov; 863():172658. PubMed ID: 31518562
[TBL] [Abstract][Full Text] [Related]
26. JS‑K induces G2/M phase cell cycle arrest and apoptosis in A549 and H460 cells via the p53/p21WAF1/CIP1 and p27KIP1 pathways.
Song Z; Yin Y; Hao S; Wei J; Liu B; Huang X; Gao C; Zhu R; Liao W; Cai D
Oncol Rep; 2019 Jun; 41(6):3475-3487. PubMed ID: 31002373
[TBL] [Abstract][Full Text] [Related]
27. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric determination of Panton-Valentine leucocidin S component binding.
Gauduchon V; Werner S; Prévost G; Monteil H; Colin DA
Infect Immun; 2001 Apr; 69(4):2390-5. PubMed ID: 11254598
[TBL] [Abstract][Full Text] [Related]
30. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
31. A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway.
Guo CL; Wang LJ; Zhao Y; Liu H; Li XQ; Jiang B; Luo J; Guo SJ; Wu N; Shi DY
Mar Drugs; 2018 Jan; 16(2):. PubMed ID: 29370087
[TBL] [Abstract][Full Text] [Related]
32. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
33. LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway.
Nie Z; Shi L; Song K; Xu X; Ding P; Lu B; Wu G; Ma X
Cell Signal; 2022 Jul; 95():110357. PubMed ID: 35589047
[TBL] [Abstract][Full Text] [Related]
34. Herbal formula Renshenwuweizi decoction induces p53-mediated cell cycle arrest and apoptosis in A549 cells.
Yu S; Zhang W; Yang J; Zhao W; Liu M; Zhao D; Bai X; Wang S
J Tradit Chin Med; 2020 Oct; 40(5):766-773. PubMed ID: 33000577
[TBL] [Abstract][Full Text] [Related]
35. The anti-non-small cell lung cancer effect of Diosbulbin B: Targeting YY1 induced cell cycle arrest and apoptosis.
Zhao JQ; Zhou QQ; Sun Y; Yu T; Jiang Y; Li HJ
Phytomedicine; 2024 Jul; 130():155734. PubMed ID: 38761775
[TBL] [Abstract][Full Text] [Related]
36. Kahweol induces apoptosis by suppressing BTF3 expression through the ERK signaling pathway in non-small cell lung cancer cells.
Jeon YJ; Bang W; Cho JH; Lee RH; Kim SH; Kim MS; Park SM; Shin JC; Chung HJ; Oh KB; Seo JM; Ko S; Shim JH; Chae JI
Int J Oncol; 2016 Dec; 49(6):2294-2302. PubMed ID: 27748804
[TBL] [Abstract][Full Text] [Related]
37. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
38. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
39. Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways.
Min J; Huang K; Tang H; Ding X; Qi C; Qin X; Xu Z
Oncol Rep; 2015 Dec; 34(6):2871-9. PubMed ID: 26503828
[TBL] [Abstract][Full Text] [Related]
40. Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.
Chen Y; Li H; Zhang W; Qi W; Lu C; Huang H; Yang Z; Liu B; Zhang L
Toxicol Appl Pharmacol; 2020 Jan; 387():114848. PubMed ID: 31809756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
